Log in to save to my catalogue

Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administrat...

Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administrat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10027951

Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques

About this item

Full title

Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2023-04, Vol.41 (17), p.2837-2845

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Highlights•Intradermal administration of a SARS-CoV-2 inactivated vaccine induced strong humoral and cellular immunity in rhesus macaques; •The SARS-CoV-2 inactivated vaccine showed good safety and immunogenicity; •There were no adverse reactions related to the SARS-CoV-2 inactivated vaccine.

Alternative Titles

Full title

Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10027951

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10027951

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2023.03.033

How to access this item